Aortic arterial stiffness is a moderate predictor of cardiovascular disease in patients with psoriasis vulgaris

Angiology

Volumn 65, Issue 1, 2014, Pages 74-78

  Balta, Ilknur ^a   Balta, Sevket ^b   Demirkol, Sait ^b   Celik, Turgay ^b   Ekiz, Ozlem ^c   Cakar, Mustafa ^b   Sarlak, Hakan ^b   Ozoguz, Pinar ^d   Iyisoy, Atila ^b  

^a Kecioren Training and Research Hospital ^*  (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c MUSTAFA KEMAL UNIVERSITY   (Turkey)

^d AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

arterial stiffness; atherosclerosis; endothelial dysfunction; high sensitivity C reactive protein; psoriasis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AORTA; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MALE; PREDICTOR VARIABLE; PSORIASIS VULGARIS; SEX DIFFERENCE; SEX DIFFERENTIATION; ADOLESCENT; BLOOD; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSORIASIS; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RISK FACTORS; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84888622204     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713485805     Document Type: Article

References (30)

1. Gisondi P, Ferrazzi A, Girolomoni G. Metabolic comorbidities and psoriasis. Acta Dermatovenerol Croat. 2010 ; 18 (4). 297-304
2. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006 ; 55 (5). 829-835
3. Yiu KH, Yeung CK, Chan HT, et al. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol. 2011 ; 164 (3). 514-520
4. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006 ; 296 (14). 1735-1741
5. Gelfand JM, Mehta NN, Langan SM. Psoriasis and cardiovascular risk: strength in numbers, part II. J Invest Dermatol. 2011 ; 131 (5). 1007-1010
6. Tziomalos K, Tziomalos K, Sivanadarajah N, Mikhailidis DP, Boumpas DT, Seifalian AM. Increased risk of vascular events in systemic lupus erythematosus: is arterial stiffness a predictor of vascular risk?. Clin Exp Rheumatol. 2008 ; 26 (6). 1134-1145
7. Ahlehoff O, Gislason GH, Charlot M, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2011 ; 270 (2). 147-157
8. Gisondi P, Fantin F, Del Giglio M, et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology. 2009 ; 218 (2). 110-113
9. Doonan RJ, Hausvater A, Scallan C, et al. The effect of smoking on arterial stiffness. Hypertens Res. 2010 ; 33 (5). 398-410
10. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial function, arterial stiffness and lipid lowering drugs. Expert Opin Ther Targets. 2007 ; 11 (9). 1143-1160
11. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica. 1978 ; 157 (4). 238-244
12. McDonald CJ, Calabresi P. Complication of psoriasis. JAMA. 1973 ; 224 (5). 629
13. McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic patients. N Engl J Med. 1973 ; 288 (17). 912
14. Ma C, Harskamp CT, Armstrong EJ, Armstrong AW. The association between psoriasis and dyslipidaemia: a systematic review. Br J Dermatol. 2013 ; 168 (3). 486-495
15. Maradit-Kremers H, Dierkhising RA, Crowson CS, Icen M, Ernste FC, McEvoy MT. Risk and predictors of cardiovascular disease in psoriasis: a population-based study. Int J Dermatol. 2013 ; 52 (1). 32-40
16. Balci DD, Balci A, Karazincir S, et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol. 2009 ; 23 (1). 1-6
17. Costa L, Caso F, D'Elia L, et al. Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol. 2012 ; 31 (4). 711-715
18. Demirkol S, Balta S, Unlu M, et al. Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness [published online November 26, 2012]. Clin Appl Thromb Hemost. 2012 ;:
19. Balta S, Cakar M, Demirkol S, et al. Arterial stiffness itself without other inflammatory markers may not provide information to clinicians [published online February 1, 2013]. J Clin Hypertens (Greenwich). 2013 ;:
20. Balta S, Demirkol S, Celik T, et al. Association between coronary artery ectasia and neutrophil-lymphocyte ratio [published online March 7, 2013]. Angiology. 2013 ;:
21. Yildiz M. Arterial distensibility in chronic inflammatory rheumatic disorders. Open Cardiovasc Med J. 2010 ; 4: 83-88
22. Bacaksiz A, Akif Vatankulu M, Sonmez O, et al. Non-dipping nocturnal blood pressure in psoriasis vulgaris. Wien Klin Wochenschr. 2012 ; 124 (23-24). 822-829
23. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013 ; 68 (4). 654-662
24. Xiao J, Chen LH, Tu YT, Deng XH, Tao J. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol. 2009 ; 23 (11). 1311-1315
25. Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS. Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol. 2009 ; 160 (1). 1-7
26. Lee JH, Cho KI, Kim SM. Carotid arterial stiffness in patients with rheumatoid arthritis assessed by speckle tracking strain imaging: its association with carotid atherosclerosis. Clin Exp Rheumatol. 2012 ; 30 (5). 720-728
27. Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol. 2005 ; 52 (2). 262-267
28. Grace AA, Barradas MA, Mikhailidis DP, et al. Cyclosporine a enhances platelet aggregation. Kidney Int. 1987 ; 32 (6). 889-895
29. Bosello S, Santoliquido A, Zoli A, et al. TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with longstanding severe rheumatoid arthritis. Clin Rheumatol. 2008 ; 27 (7). 833-839
30. Papadakis JA, Sidiropoulos PI, Karvounaris SA, et al. High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNF alpha treatment: correlation with disease activity. Clin Exp Rheumatol. 2009 ; 27 (2). 292-298